BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37904985)

  • 1. LKB1 suppresses growth and promotes the internalization of EGFR through the PIKFYVE lipid kinase.
    Ferrarone JR; Thomas J; Unni AM; Zheng Y; Nagiec MJ; Gardner EE; Mashadova O; Li K; Koundouros N; Montalbano A; Mustafa M; Cantley LC; Blenis J; Sanjana NE; Varmus H
    bioRxiv; 2023 Oct; ():. PubMed ID: 37904985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase.
    Ferrarone JR; Thomas J; Unni AM; Zheng Y; Nagiec MJ; Gardner EE; Mashadova O; Li K; Koundouros N; Montalbano A; Mustafa M; Cantley LC; Blenis J; Sanjana NE; Varmus H
    Proc Natl Acad Sci U S A; 2024 May; 121(21):e2403685121. PubMed ID: 38743625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of tumor suppression by LKB1.
    Vaahtomeri K; Mäkelä TP
    FEBS Lett; 2011 Apr; 585(7):944-51. PubMed ID: 21192934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation.
    Murray CW; Brady JJ; Tsai MK; Li C; Winters IP; Tang R; Andrejka L; Ma RK; Kunder CA; Chu P; Winslow MM
    Cancer Discov; 2019 Nov; 9(11):1590-1605. PubMed ID: 31350327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap.
    Nguyen HB; Babcock JT; Wells CD; Quilliam LA
    Oncogene; 2013 Aug; 32(35):4100-9. PubMed ID: 23027127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
    Hollstein PE; Eichner LJ; Brun SN; Kamireddy A; Svensson RU; Vera LI; Ross DS; Rymoff TJ; Hutchins A; Galvez HM; Williams AE; Shokhirev MN; Screaton RA; Berdeaux R; Shaw RJ
    Cancer Discov; 2019 Nov; 9(11):1606-1627. PubMed ID: 31350328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.
    Shukuya T; Yamada T; Koenig MJ; Xu J; Okimoto T; Li F; Amann JM; Carbone DP
    J Thorac Oncol; 2019 Jun; 14(6):1061-1076. PubMed ID: 30825612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
    Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
    Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.
    Liu M; Jiang L; Fu X; Wang W; Ma J; Tian T; Nan K; Liang X
    Cancer Sci; 2018 Oct; 109(10):3055-3067. PubMed ID: 30033530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LKB1 suppresses p21-activated kinase-1 (PAK1) by phosphorylation of Thr109 in the p21-binding domain.
    Deguchi A; Miyoshi H; Kojima Y; Okawa K; Aoki M; Taketo MM
    J Biol Chem; 2010 Jun; 285(24):18283-90. PubMed ID: 20400510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.
    Liu Y; Marks K; Cowley GS; Carretero J; Liu Q; Nieland TJ; Xu C; Cohoon TJ; Gao P; Zhang Y; Chen Z; Altabef AB; Tchaicha JH; Wang X; Choe S; Driggers EM; Zhang J; Bailey ST; Sharpless NE; Hayes DN; Patel NM; Janne PA; Bardeesy N; Engelman JA; Manning BD; Shaw RJ; Asara JM; Scully R; Kimmelman A; Byers LA; Gibbons DL; Wistuba II; Heymach JV; Kwiatkowski DJ; Kim WY; Kung AL; Gray NS; Root DE; Cantley LC; Wong KK
    Cancer Discov; 2013 Aug; 3(8):870-9. PubMed ID: 23715154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit angiogenesis.
    Okon IS; Coughlan KA; Zhang C; Moriasi C; Ding Y; Song P; Zhang W; Li G; Zou MH
    J Clin Invest; 2014 Oct; 124(10):4590-602. PubMed ID: 25180605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LKB1 kinase-dependent and -independent defects disrupt polarity and adhesion signaling to drive collagen remodeling during invasion.
    Konen J; Wilkinson S; Lee B; Fu H; Zhou W; Jiang Y; Marcus AI
    Mol Biol Cell; 2016 Apr; 27(7):1069-84. PubMed ID: 26864623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of E-cadherin/AMPK/mTOR axis in LKB1-induced sensitivity of non-small cell lung cancer to gambogic acid.
    Li X; Tang X; Su J; Xu G; Zhao L; Qi Q
    Biochem Pharmacol; 2019 Nov; 169():113635. PubMed ID: 31513784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.
    Faubert B; Vincent EE; Griss T; Samborska B; Izreig S; Svensson RU; Mamer OA; Avizonis D; Shackelford DB; Shaw RJ; Jones RG
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2554-9. PubMed ID: 24550282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin.
    Zhang W; Gao Y; Li F; Tong X; Ren Y; Han X; Yao S; Long F; Yang Z; Fan H; Zhang L; Ji H
    Cancer Res; 2015 Nov; 75(21):4450-7. PubMed ID: 26363011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.
    Fernandez P; Carretero J; Medina PP; Jimenez AI; Rodriguez-Perales S; Paz MF; Cigudosa JC; Esteller M; Lombardia L; Morente M; Sanchez-Verde L; Sotelo T; Sanchez-Cespedes M
    Oncogene; 2004 Jun; 23(29):5084-91. PubMed ID: 15077168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver kinase B1 restoration promotes exosome secretion and motility of lung cancer cells.
    Zhang C; Xiao X; Chen M; Aldharee H; Chen Y; Long W
    Oncol Rep; 2018 Jan; 39(1):376-382. PubMed ID: 29138862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LKB1 tumor suppressor protein: PARtaker in cell polarity.
    Baas AF; Smit L; Clevers H
    Trends Cell Biol; 2004 Jun; 14(6):312-9. PubMed ID: 15183188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.